Hospital of the University of Pennsylvania
Hematology and Oncology fellowship · Philadelphia, PA · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Pennsylvania's research in hematology and oncology, which the program shares with other departments and affiliated hospitals.
About University of Pennsylvaniainstitution-wide hematology and oncology research
Hematology and Oncology publications from University of Pennsylvania and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
636
works per year
2nd of 74 hematology and oncology fellowship programs
+13.9%
2-year growth
33rd of 74 hematology and oncology fellowship programs
38.6%
in top 10% of field (works before 2025)
1st of 72 hematology and oncology fellowship programs
56.1%
cited above world average
1st of 72 hematology and oncology fellowship programs
Works per year · * 2026 so far
Oncology · 2,114Hematology · 1,015
Hematology and Oncology research topics at University of Pennsylvania
Papers in the window; each links to the list on OpenAlex.
- CAR-T cell therapy research 583
- Cancer Immunotherapy and Biomarkers 293
- Acute Myeloid Leukemia Research 266
- Hematopoietic Stem Cell Transplantation 177
- Pancreatic and Hepatic Oncology Research 148
- Cancer survivorship and care 126
- Cutaneous Melanoma Detection and Management 101
- Multiple Myeloma Research and Treatments 100
Most cited at University of Pennsylvania since 2024
All hematology and oncology papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in OncologyAl B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 406
- Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim resultsStephen Joseph Bagley et al. · Nature Medicine · 2024 · PubMed · cited 405
- In vivo CAR T cell generation to treat cancer and autoimmune diseaseTheresa Hunter et al. · Science · 2025 · PubMed · cited 360
- Cardiovascular disease and cancer: shared risk factors and mechanismsNicholas S. Wilcox et al. · Nature Reviews Cardiology · 2024 · PubMed · cited 330
- Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistanceGh. Rasool Bhat et al. · Cancer and Metastasis Reviews · 2024 · PubMed · cited 313
- NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024Al B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 312
- Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancersDavid Steffin et al. · Nature · 2024 · PubMed · cited 300
- Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic CancerJulien Dilly et al. · Cancer Discovery · 2024 · PubMed · cited 295
- LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunityLawrence Peter Andrews et al. · Cell · 2024 · PubMed · cited 292